Peter Fong serves as Executive at ROCKET PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Peter Fong has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 24, 2025 involved receiving (via award) 30,000 shares valued at $0.
Peter Fong currently holds 53,333 shares of ROCKET PHARMACEUTICALS, INC. (RCKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Fong has been a net neutral trader of RCKT stock. They have purchased $0 and sold $0 worth of shares.
Peter Fong's most recent insider trade was on Sep 24, 2025, when they sold 30,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |